If a researcher introduces an anti-IgE antibody into a patient experiencing seasonal allergies, which consequence affecting mast cell activity is most likely?

💡 Explanation

Introducing anti-IgE antibodies reduces mast cell activation because these antibodies bind to free IgE, preventing its attachment to FcεRI receptors on mast cells; therefore, mast cell degranulation and histamine release are inhibited, rather than enhanced, thus lessening allergic symptoms.

• Why does drug dosage adjustments based on patient weight fail when treating a highly lipophilic drug exhibiting extensive tissue binding?
• In skeletal muscle during intense chronic stress, why does protein degradation via the ubiquitin-proteasome pathway (UPP) accelerate relative to protein synthesis?
• Why does hypertension damage blood vessel walls more rapidly than in normotensive individuals?
• If a patient's peripheral arteries constrict due to hypothermia, which consequence follows regarding mean arterial pressure?
• If a person experiences hypocalcemia, and the voltage-gated sodium channels of the neuromuscular junction become more sensitive, which consequence follows?
• An astronaut on a prolonged space mission experiences increased 2,3-BPG levels in their red blood cells. Which effect becomes more likely due to this physiological adaptation?